Status:
COMPLETED
Transcorneal Electrical Stimulation Therapy for Retinal Disease
Lead Sponsor:
Okuvision GmbH
Conditions:
Retinitis Pigmentosa
Macula Off
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Transcorneal stimulation may enable neurons to survive degeneration processes via enhanced secretion of neurotrophic substances and direct stimulation of neurons.
Eligibility Criteria
Inclusion
- Retinitis pigmentosa, Macula off, Primary open angle Glaucoma, Hereditary Macular Degeneration, Treated Retina detachment, Retinal Artery Occlusion, Retinal Vein Occlusion, Non-Arthritic-Anterior-Ischemic Optic-Neuropathy, Hereditary autosomal dominant Optic atrophy, dry Age-related Macular Degeneration, Ischemic Macula edema
Exclusion
- Severe other disease such as non-proliferative diabetic retinopathy, exudative Age-related Macular Degeneration
- Age above 99 years
Key Trial Info
Start Date :
January 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00804102
Start Date
January 1 2008
End Date
April 1 2011
Last Update
May 4 2012
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.